• Oral Dextran Microgels for Local Colon Cancer Therapy

  2026-09-29

  The reference study develops an orally administered, sequentially targeted system that combines dextran microgels with cisplatin/SPION lipid nanoparticles for localized colon cancer treatment. Its design links colon-specific enzymatic release, folate-receptor-mediated uptake, and magnetic hyperthermia to improve tumor control while limiting systemic exposure.

• Vitamin C Workflows for Cancer and HEV Organoids

  2026-09-29

  Build reproducible ascorbic acid dose–response workflows for tumor-cell assays while using multilineage organoids to test tissue-specific injury and host responses. The approach separates established anticancer evidence from exploratory HEV applications, helping researchers avoid mistaking general cytotoxicity for antiviral activity.

• AR and ARv7 in TNBC: EPI-001 Study Insights

  2026-09-28

  This 2025 study links androgen receptor (AR) and AR splice variant 7 (ARv7) expression with unfavorable outcomes and metastatic risk in triple-negative breast cancer (TNBC). In MDA-MB-231 cells, pharmacologic targeting with enzalutamide or the androgen receptor N-terminal domain inhibitor EPI-001 altered migration- and epithelial-to-mesenchymal transition-associated markers, supporting ARv7-focused investigation in TNBC.

• PX-478 2HCl in Hypoxia Signaling Research

  2026-09-28

  PX-478 2HCl offers a practical way to perturb HIF-1α in cell-based hypoxia studies and selected in vivo models. A prenatal-hypoxia rat study extends its research use into neurodevelopmental assays, while also highlighting why timing, safety readouts, and model-specific validation matter.

• 4μ8C Workflows for ER Stress Research

  2026-09-27

  Use 4μ8C to separate IRE1α RNase-dependent stress signaling from cell-growth outcomes in hypoxia and cancer cell models. This guide pairs practical dose-finding and pathway readouts with clear limits: the compound is a preclinical in vitro tool, not an established in vivo treatment.

• Alfuzosin HCl: From Receptor Biology to Assay Design

  2026-09-26

  Explore how Alfuzosin HCl connects α1-adrenoceptor pharmacology with practical assay design for benign prostatic hyperplasia research. A micellar spectrofluorimetric study illustrates when fluorescence can support measurements in tablets and biological samples—and where matrix-specific validation remains essential.

• Cy5 Detection in Exosomal Wnt10a Osteogenesis

  2026-09-25

  A translational perspective on validating lithium–exosome osteogenesis mechanisms with fluorescence assays, and on selecting a Cy5 secondary antibody for mouse-primary detection.

• Lysoptosis: A Conserved Serpin-Regulated Death Pathway

  2026-09-25

  The study identifies lysoptosis as a lysosome-dependent cell-death pathway that is distinct from lysosomal damage accompanying other forms of regulated cell death. Findings across nematode, mouse, and human systems link loss of intracellular serpins to lysosomal membrane permeabilization and cathepsin-dependent cell death, providing a framework for testing when lysosomes act as executioners rather than bystanders.

• Chenodeoxycholic Acid: FXR Evidence & Research Use

  2026-09-24

  Chenodeoxycholic Acid (CDCA) is a primary bile acid and FXR activator used to investigate bile acid metabolism and nuclear receptor signaling. A 2026 preclinical study reports that CDCA activated an FXR–KLF11 pathway associated with reduced kidney injury in mouse and cell models, but does not establish clinical efficacy.

• Patient-Derived Spheroids Model Localized Prostate Cancer

  2026-09-24

  This study established viable, cryopreservable three-dimensional spheroid cultures from radical prostatectomy tissue across 109 cases, addressing a shortage of models for organ-confined prostate cancer. The spheroids retained several prostate epithelial markers and showed distinct responses to tested drugs, while their lack of response to abiraterone highlights the need to assess drug activity in the context of each model’s biology.

• miR-196a Drives EAC Through the MYC/TERT/NFκB Axis

  2026-09-23

  A 2025 study links miR-196a to epithelial-to-mesenchymal transition, greater motility, and NFκB activation in esophageal adenocarcinoma cells. Its experiments support a signaling model in which reduced VCP and NFKBIA expression connect miR-196a with c-MYC accumulation, TERT upregulation, and more aggressive cell behavior.

• Cyanine 5-dCTP for DNA Fluorescent Probe Synthesis

  2026-09-23

  Cyanine 5-dCTP adds a red-fluorescent handle to enzymatically produced DNA, supporting PCR labeling, probe construction, and nucleic acid detection. This guide combines practical incorporation strategies with the ordered DNA-framework concept reported for higher-yield enzymatic oligonucleotide synthesis.

• Human iPSC Models for Schizophrenia and Bipolar Disorder

  2026-09-22

  This resource study established and characterized three human induced pluripotent stem cell lines from two cousins with schizophrenia or bipolar disorder and an unaffected cousin. The family-linked design provides a practical foundation for investigating neurodevelopmental mechanisms, although disease-relevant neuronal phenotypes and molecular comparisons remain to be developed.

• Repeated Degarelix Treatment in Goats: Study Insights

  2026-09-22

  This 2020 study found that repeated subcutaneous degarelix acetate treatment produced sustained suppression of testosterone and INSL3, reduced testicular measures, and eliminated detectable sperm in young male goats. The work extends GnRH receptor antagonist research from short-term endocrine suppression to a multidimensional assessment of chemical castration, while also defining important limits for translation to other reproductive or clinical settings.

• TSPAN18–STIM1 Signaling in Prostate Cancer Bone Metastasis

  2026-09-21

  Zhou et al. identify TSPAN18 as a regulator of STIM1 stability, showing that it protects STIM1 from TRIM32-mediated ubiquitination and sustains calcium entry linked to prostate cancer bone metastasis. The study connects protein-protection mechanisms with metastatic behavior and provides a framework for investigating the TSPAN18–STIM1–Ca2+ axis in follow-up models.

8557 records 1/571 page Next 12345 下5页 Last page